Anaesthesia as a risk factor for long-term cognitive decline: Results of the prospective MAAS cohort study.
Summary
In a 12-year prospective cohort (n=1,823) with repeated cognitive testing, greater baseline cumulative exposure time to general anesthesia was independently associated with worse trajectories in executive function (CST), selective attention/mental speed (Stroop), and information processing speed (LDST). Age and education remained dominant contributors, while hypertension, diabetes, and smoking also adversely affected cognitive domains.
Key Findings
- Longer cumulative time under general anesthesia at baseline predicted worse longitudinal performance in executive function (CST, P<0.05), attention/mental speed (Stroop, P<0.001), and processing speed (LDST, P<0.005).
- Age and education were the strongest determinants of lifetime cognitive decline; hypertension, diabetes, and smoking also had adverse associations.
- Prospective design with three serial assessments over 12 years in 1,823 adults enhances causal inference compared with cross-sectional studies.
Clinical Implications
Include potential long-term cognitive risks in shared decision-making for patients requiring multiple surgeries; minimize anesthesia exposure where feasible, optimize vascular risk factors (hypertension, diabetes, smoking), and consider cognitive monitoring in high-risk individuals.
Why It Matters
This large, long-term cohort contributes rigorous evidence to a debated question, quantifying the association between cumulative anesthesia exposure and domain-specific cognitive decline beyond demographic and health risk factors.
Limitations
- Observational design with potential residual confounding; anesthesia exposure quantified as total time at baseline without detailed anesthetic agents/dose.
- Surgical pathology and perioperative factors may contribute to cognitive change and are difficult to fully disentangle.
Future Directions
Integrate granular anesthetic exposure metrics (agents, depth, burst suppression) and perioperative complications; emulate target trials to clarify causality; test mitigation strategies (depth-guided anesthesia, neuroprotective protocols).
Study Information
- Study Type
- Cohort
- Research Domain
- Prognosis
- Evidence Level
- II - Prospective longitudinal cohort with adjusted analyses.
- Study Design
- OTHER